APA (7th ed.) Citation

Vermeulen, S., Awada, G., Keyaerts, M., Neyns, B., & Everaert, H. (2021). Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome. MDPI AG.

Chicago Style (17th ed.) Citation

Vermeulen, Sim, Gil Awada, Marleen Keyaerts, Bart Neyns, and Hendrik Everaert. Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome. MDPI AG, 2021.

MLA (8th ed.) Citation

Vermeulen, Sim, et al. Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome. MDPI AG, 2021.